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Mutations of exons 3 through 9 of the p53 gene in skin 
lesions were screened in 23 cases of squamous cell carcinoma 
(SCe), 25 cases of basal cell carcinoma (BCe), two cases of 
Bowen's disease, 10 cases of solar keratosis, and five cases of 
keratoacanthoma by polymerase chain reaction - single 
strand conformation polymorphism analysis. Mutations of 
the p53 gene were detected in seven of23 SCCs (30%), three 
of25 BCCs (12%), and none in all cases of Bowen's disease, 
solar keratosis, or keratoacanthoma. Of 23 cases of see, 
mutations were detected in four of 15 SCCs (27%) that orig-
inated in the sunlight-exposed skin region, in two of three 
SCCs (67%) that originated in the scar tissue, and in one of 
three SCCs (33%) that originated in radiation dermatitis. 
Mutations of C ---+ T transition predominated in see and 
BCC that originated in the sunlight-exposed skin region. 
Activation of ras oncogenes and inactivation of the p53 tumor suppressor gene are two frequently observed major molecular etiologies for human tumorigenesis [1-3]. Although exposure to the UV light in sunlight works as a carcinogenic stimulus in the case of skin 
cancers [4,5]' the molecular mechanism of skin carcinogenesis is not 
well understood. Although the allelic loss of chromosome 9q was 
reported to be present in 69% (11 of 16) of sporadic basal cell 
carcinoma (BCC) and 100% (three of three) ofGorlin syndrome, an 
autosomal dominant disorder with predisposition to BCCs or other 
tumors [6], the role of activation of oncogenes or inactivation of 
tumor suppressor genes in the initiation or progression ofBCCs has 
not been clarified. 
Our immunohistochemical analysis of skin tumors with two 
mouse monoclonal anti-p53 antibodies of PAb421 and PAb1801 
[7], or with another mouse monoclonal anti-p53 antibody (I?07) 
and a rabbit polyclonal antl-p53 antibody (CM1) (manuscript In 
preparation), disclosed the increased expression of th~ p53 pr?tein 
product in sq~a~nous cell carCInomas (SCCs)~ showmg a hlg~ler 
incidence in climcally advanced stages [7]. The lllcreased expressIOn 
of the p53 protein product has been regarded co be due to the 
accumulation of the mutant p53 proteins [8,9]. Mutations of the p53 
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Mutations of C ---+ A or CC ---+ AT observed in tumors that 
originated in the predisposed conditions, presumably unre-
lated to UV light, are different from those found in UV 
light-related SCC or BCe. Twelve cases of SCC were com-
paratively analyzed with the immunohistochemical staining 
with anti-p53 antibody. Two of four cases with positive 
staining had missense mutations, and three of eight cases 
with negative staining had nonsense mutations. Based on 
these findings, immunohistochemical results do not neces-
sarily mean the presence or absence of p53 gene mutations in 
skin tumors, and sequence analysis is essential for determin-
ing whether the gene is mutated. Key words: squamous cell 
carcinoma/basal cell carcinoma/solar keratos;s/PCR-SSCP.] In-
vest DermatoI102:440-444, 1994 
gene were frequently reported in invasive SCCs and BCCs of the 
skin in Caucasians [10-14] . In this study, the role of p53 gene 
mutations in the skin carcinogenesis was exam.ined in the Japanese 
population. Mutations of the p53 gene were first screened by 
polymerase chain reaction-single strand conformation polymor-
phism (PCR-SSCP) analysis in SCC, BCC, Bowen's disease, solar 
keratosis (which is regarded to be a precancerous condition of SCC 
[15]), and keratoacanthoma, which is a self-regressing benign tumor 
having atypical cells resembling those ofscc [16]. The presence of 
confirmed mutations of the p53 gene by sequencing was then com-
pared with the expression of p53 protein product analyzed by im-
munohistochemical staining methods. 
MATERIALS AND METHODS 
DNA Samples We analyzed 23 cases of SCC including 14 well differen-
tiated, six moderately differentiated , and three poorly differentiated. 
Twenty-one cases were primary lesions and two cases were recurrent lesions. 
Twenty-three cases ofSCC were divided into two groups: group 1 contained 
15 cases of SCC that originated in the sunlight-exposed skin regions, and 
group 2 contained another eight cases of SCC that were supposed to be 
minimally related to UV light, including three cases ofSCC that originated 
in the scar tissue, three cases ofSCC that originated in radiation dermatiris, 
one case of SCC that occurred in the femora l region, and one case of SCC 
that occurred in the external genital organ. In addition, 25 cases ofBCC that 
originated in the sunlight-exposed skin regions, two cases of Bowen's dis-
ease, 10 cases of solar keratosis including six of the hypertrophic type and 
four of the atrophic type, and five cases of keratoacanthoma were analyzed. 
Of 65 samples in total, 28 were frozen samples, and 37 were formalin-
fixed samples embedded in paraffin. High molecular weight genomic DNA 
was prepared from frozen samples by proteinase K digestion and phenol! 
chloroform extraction [17J. DNA was isolated from paraffin-embedded tis-
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Table I. Oligonucleotide Primers to Amplify Exons 3 Through 9 of the p53 Gene" 



















• The direction of the base sequence is from 5' to 3'. 
sue as previously re~orted [18). In brief, portions containing skin lesions in 
etions 5 jim in thIckness were scraped from a glass slIde by a razor blade 
se' th regard to the microscopic observation of hematoxylin and eosin-
:ined samples. Because tumor regions ~re limite~ to the thin epidermis in 
solar keratosis of the atrophIc typ.e, we trIed to eXCIse tumor regIOns 111clud-
ing as little normal tissue as possIble. 
PCR-SSCP Analysis PCR-SSCP analys is was performed as described by 
o 'ta et af with a slight modification [19). We synthesized oligonucleotide ~:ners by the phosphoramidite method using a 392 DNA synthesizer f~pp l ied Biosystems, Inc., Foster City, CAl [18). We screened mutations in 
xons 3 through 9 of the p53 gene. Oligonucleotide primers to amplify 
e xons 3 through 9 are listed in Table I. Genomic DNA (50 ng) were sub-~eeted to 30 cycles of PCR at 94,55, and 72°C for I, 1, and 2 min, respec-
{'vely for denaturation, annealing, and elongation in 5 pi of reaction mix-t~re ~ontaining [a_32P] dCTP (3000 Ci/mmol; 10 mCi/ml) . The PCR 
roducts in 5 pi were diluted 50 times with the loading solution (95% 
formamide, 20 mM ethylenediamine tetraacetic acid [EDTA], 0.05% xy-
lene cyanol, 0.05% bromop~1enol blue), and heate~ at 94·C for5 min and 
'mmediately chilled Itl an Ice bath. One mIcrolIter of the mIxture was ~pplied to a 6% polyacrylamide gel containing 45 mM Tris borate (pH 8.3) 
and 4 mM EDTA in three conditions including 0, 5, or 10% glycerol. 
Electrophoresis was performed at 20 W for 3 - 6 II at room temperature with 
constant coolin g by a fan. The gel was drIed on fi lter paper and exposed to an 
X-ray film for 4 -24 h at -80·C with an intensifying screen. PCR-SSCP 
was repeated at least twice to e~sure that the results were reproducible in 
each case showing a mobIlIty sh Ift. 
Direct Sequencing Bands with altered migration in SSCP analysis were 
excised from the dried gel, incubated at 55·C for 2 h in 100 pI of distilled 
water. For direct sequencing, this supernatant was amplified by PCR with 
primers that have an M13 sequence at the 5' end of one primer and an M 13 
reverse sequence at the 5' end of another primer. After purifying the PCR 
products by spin filtration on a SUPREC-2 (Takara Shuzo Co. Ltd., Kyoto, 
Japan), the double-stranded DNA fragments were directly sequenced by 
fluorescence-based dideoxy-terminatioll methods using an Applied Biosys-
terns Model 373A automated DNA sequencer (Applied Biosystems, Inc.). 
RESULTS 
PCR-SSCP Analysis Results of PCR-SSCP analysis of exons 3 
through 9 of the p53 gene are shown in Fig 1. In 11 cases ofSCC or 
Bec, extra bands with altered migration were detected relative to 
those amplified from normal leukocyte DNAs of a healthy control 
subject. Eight cases were SCCs and three cases were BCCs. The 
exons that showed altered migration in eight cases ofSCCs include 
exons 3, 4,5,7, and 9. Altered migrations in three cases ofBCCs 
were all in exon 5. In any case with an extra band(s), no obvious loss 
of heterozygosity was detected. No cases with Bowen's disease, 
solar keratosis, or keratoacanthoma showed extra bands. 
Direct Sequencing In eight cases of SCC and 3 cases of BCC 
with extra bands, DNA samples eluted from the dried gel were 
amplified and directly sequenced. As shown in Fig 2, mutations 
were identified in comparison with the sequence of normal leuko-
cytes DNA of a healthy normal control subject. 
In SCCs, mutations were detected in seven of 23 cases (30%). 
One case ofSCC had arolymorphism ofT in place of A at the third 
base from the 5' end 0 intron 3. Five of 21 primary lesions (24%) 
and two of two recurrent lesions (100%) had mutations. As summa-
rized in Table II, mutations were detected in four of 15 cases (27%) 
ofSCC that originated in the sunlight-exposed skin regions (group 
1), in two of three cases (67%) of SCC that originated in the scar 
tissue, and in one of three cases (33%) of SCC that originated in 
radiation dermatitis (group 2). One sample had double base muta-
tion (CC --.. AT), and six other samples had point mutations. The 
sites of detected mutations were at codon 107 in exon 4, at codon 
178 and 179 in exon 5, at codon 234, 244, and 249 in ex on 7, and at 
codon 317 and 326 in exon 9. Three of seven mutations were 
missense mutations with substituted amino acids. On the other 
hand, four of seven were nonsense mutations with the formation of 
stop codons. 
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Figure 1. SSCP analysis of exons 3-4, 5, 7, and 9 of the p53 gene in SCCs 
and BCCs. A, B, C, and D) results ofSSCP analysis of exon 3-4, 5, 7, and 9, 
respectively. Every even-numbered lane shows coorrol using normalleuko-
cyte DNA as a template. A) lalle 1, SCC that corresponds to SCC 1 in Table 
II; fall e 3, SCC that was later shown by direct sequencing to have a polymor-
phism ofT in place of A at the third base from the 5' end ofintron3. B) fall e 
1, SCC 5; lalle 3, BCC 1; lalle 5, BCC 2; lalle 7, DCC 3. C) lalle 1, SCC 2; lalle 
3, SCC 3; lalle 5, SCC 6. D) lalle 1, SCC 4; lalle 3, SCC 7. Elecrrophoresis was 
performed in a 6% polyacrylamide gel including 0% glycerol (fall es 7, 8 III 
B), 5% glycerol (falles 1-4 in B, falles 1, 2, 5, and 6 in C) , or 10% glycerol 
(fall es 1-3 in A, lalles 5 alld 6 in B, falles 3,4 in C, and lalles 1-410 D). Every 
odd-numbered lane shows a band(s) with altered migration relative to con-
trols. 
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Figure 2. Typical examples of nucleotide sequencing of the p53 gene, 
Results of two of 11 samples are shown, A) tipper panel, the normal sequence 
of codon 233 - 236; lower panel, the sequence of the band with altered migra-
tion in ssep analysis. This corresponds to sec 5 in Table II, and showed 
e --> A transversion at codon 234. B) Whereas the IIpper pallel shows the 
normal sequence of codon 315 - 318, the lower panel shows the sequence of 
the band with altered migration detected in DNA samples of sec 3, e --+ T 
transition at codon 317 is shown, Asterisk, the base at which mutation was 
detected, 
In BCCs, mutations were detected in three of25 cases (1 2%). All 
three samples had missense point mutations, and the sites of muta-
tions were at codon 169, 170, and 177 in exon 5. Five of seven cases 
(71 %) in subjects including group 1 of SCCs and BCCs, both of 
which were supposed to be etiologically related to UV light expo-
sure, showed C -> T transition. In group 2 of SCC, two cases had 
C -> A transversion and one case had a CC -> AT double base 
substitution. 
Comparison of the Presence or Absence of Mntations with 
Immunohistochemical Analysis of the Expression of the p53 
Protein Product in SCC The detected point mutations were 
compared with the resu~ts of imm~nohistochemical analysis of the 
expression of p53 protem product ~n 12 cases of SCC that we ~ad 
previously reported [7] . As summan~~d m Ta~le Ill, two cases with 
missense mutations were both pOSitively stamed. All three cases 
with nonsense mutations were negatively stained. When the result 
was analyzed from the staining characteristics as the first classifying 
criteria, two of four positive cases in the unmunohistochemical 
analysis had missense mutations, but no mutations could be detected 
in the remaining two cases. Three of. eight negative cas~ ha~ non-
sense mutations, whereas no mutatIOn could be detected m the 
remaining five negative cases. 
DISCUSSION 
UV light-induced mutagenesis is thought to play an important role 
in skin carcinogenesis [4,5], which occurs at dipyrimidine sites as 
the main target [20,21]. Two major photoproducts of a cyclobutane 
pyrimidine dimer and a pyrimidine-pyrimidone (6-4) photoproduct 
have been identified [22,23] . With regard to base substitutior:s, 
C -> T transitions predominated, and the CC -> TT double-base 
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
substitution was thought to be a specific UV light-induced muta-
tion [20,21,24]. In our cases, in group 1 of SCC and BCC, which 
were supposed to be etiologically attributable to UV light, 71 % 
(five of seven) of all mutations occurred at the dipyrimidine sites, 
but two samples had mutations at a pyrimidine between two pu-
rines, namely aCg -> aGg and aCg -> aTg. Because its site was at a 
CpG dinucleotide in both cases, which is a mutation hotspot by 
itself [25] , these mutations may be unrelated to UV light exposure. 
With reference to base substitutions, five of seven cases had C -> T 
transition, and two other cases had C -> G transversion. In cases of 
SCC and BCC, which were attributable to UV light, the C -> T 
transition predominated. 
On the other hand, in group 2 of SCC, which was thought to be 
minimally related to UV light, two cases had a C -> A transversion, 
and one case had a CC -> AT double-base substitution. A CC -> 
AT double base substitution instead of a CC -> TT substitution is 
supposed to be a rare mutation, but the cause for this double muta-
tion is unknown. These C -> A or CC -> AT mutations observed 
in tumors that originated in the predisposed conditions, presumably 
unrelated to UV light, are apparently different from the predomi-
nant mutation of the C -> T transition observed in tumors that 
originated in sunlight-exposed skin regions. 
In 12 SCCs, we compared the p53 gene mutations with the 
expression of the p53 protein product analyzed by immunohisto-
chemical staining with anti-p53 antibodies [7]. Two of four posi-
tively staining samples in SCCs had missense mutations. In two 
other samples, mutations could not be detected. Several possible 
reasons exist for this discrepancy in these two samples. The first 
possibility is that we overlooked mutations. Because mutations out-
side exons 3 through 9 were not screened in this study, mutations in 
exons 2, 10, and 11, which are also translated to the p53 protein 
product, may explain the discrepancy, but these mutations are re-
ported to be extremely rare in incidence [3]. Another possibility of 
missing the detection of mutations by PCR-SSCP analysis seems 
unlikely, because we performed PCR-SSCP analysis in three condi-
tions including 0, 5, or 10% glycerol. Screening in these three 
conditions should cause a very low incidence of overlooked muta-
tions [26] . The third possibility is the actual absence of mutations. 
Whereas p53 staining is not usually observed in normal skin, it was 
recently reported that UV-light exposure within 2 h can give posi-
tive immunohistochemical staining, which is attributable to the 
transient overexpression of normal p53 protein [27]. 
Three of eight negative cases had nonsense mutations, and five 
other cases had no mutations. Stabilization of mutant p53 protein 
was reported to be largely due to the complex formation of p53 
protein with other proteins, such as a heat shock protein (hsp70), as 
a result of missense mutations [8,9] . Furthermore, it was shown that 
self-aggregation of p53 protein prevents its rapid degradation [28J . 
Because oligomerization of p53 protein depends on its C-terrnitlUs 
peptide sequence [29]' immature p53 protein that lacks the C-ter-
minus by nonsense mutation is supposed to cause rapid degradation. 
In lung cancers, the absence of mature p53 protein product due to 
deletions or nonsense mutations was reflected by negative staining 
in immunohistochemical analysis [30] , which is compatible with 
negative staining in our three cases of SCCs with nonsense muta-
tions. 
In reference to the contribution ofuV light exposure to carcino-
genesis of SCCs, the incidence of p53 gene mutations was 27% 
(four of 15) in group 1 ofSCC, whereas no mutation was detected in 
10 samples of solar keratosis, a precancerous lesion before develop-
ing SCc. In our cases, it is supposed that p53 gene mutations may 
occur as a late event in the carcinogenesis of SCC. To the contrary, 
Sim et al recently reported that positively staining samples were 
observed in 28 of38 cases (74%) of solar keratosis [31]. The discrep-
ancy between our low incidence of p53 gene mutation and their 
high incidence of overexpressed p53 protein products in solar kera-
tosis may be due to UV -induced transient overexpression of normal 
p53, racial differences, or regional differences. In group 2 of scc, 
which was supposed to be minimally related to UV light, mutations 
were detected in two of three cases (67%) that originated in the scar 
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Table II. Summary of Detected Mutations of the p53 Gene in SCCs and BCCs 
Age Exon Base Amino Acid Predisposing 
(Sex) Site Codon Sequence' Change C hange Conditionsb 
sec 
Group l ' 
93 (F) Lowerjaw Exon 4 1 taCgg C->G T yr -> stop (-) 
107 
2 79 (M) Ea.r lobe Exon 7 gcCca C->T Gly -> Ser (- ) 
244 
3 93 (F) Cheek Exon 7 gcCtc C->G Arg -+ Tyr (-) 
249 
4 73 (M) Temple Exon 9 ccCag C-> T GIn -> stop (-) 
317 
Group 2J 
68 (M) 5 Lower limb Exon 5 caCCat CC->AT His -+ Gin R 
178, 179 His -+ Tyr 
6 48 (F) Lower limb Exon 7 taCaa C->A T yr -> stop S 
234 
7 88 (F) H ead Exon 9 ttCtc C-+A Glu -+ stop S 
326 
Bee 
1 78 (F) Lower eyelid Exon 5 gtCat C-+T M et -> lie (-) 
169 
2 6 1 (M) N ose Exon 5 gaCgg C->T T yr-> Met XP 
170 
3 76 (M) Nose Exon 5 ccCcc C->T Pro -> Leu (-) 
177 
• Letters show a normal sequence , whereas capital letters denote the normal base at wh.ich mutations were detected. 
" (_) , absence o f predisposing conditions; R, radiation dermatitis; S, scar tissue; and XP, xeroderma pigmencosum. 
, In SCC, group 1 includes 15 cases that originated in the sunlight-exposed skin regions.. . . . 
J Group 2 includes another eight cases that were supposed to be minimally telated to UV light, includmg thtee cases that ongmated 111 the scar tissue and three cases that originated 
in radiation dermatitis. 
tissue. and in one of three cases (33% ) that originated in radiation 
dermatitis. Althoug h the number of samples is limited . our results 
are consistent with the interpretation that p53 gene mutations m ay 
play an important e tiologic role in forming SCC w ith the associated 
predisposed conditions. 
Compared with the reported incide nce of p53 gene mutations in 
BCCs in Caucasians of about 50% [12-14). the mutation incidence 
of three of 25 cases (12% ) in the Japanese population in this study 
was sm al l. The racia l or regional differe nce m ay account for the 
observed differe n ce in the incide nce of p53 mutatiollS in BCCs. 








Table III. Comparison of p53 Gene Mutations 
with the Expression of p53 Protein Product 
by Immunohistochemical Analysis' 
Presence (+) or 
Absence (-) of 
Presence (+) Overexpression 
or Absence (-) Location and of the p53 
of Mutations Amino Acid Change Protein Product 
(+) Exon 5 (+) 
Codon 178 His-> GIn 
179 His ->Tyr 
(+) Exon 7 (+) 
Codon 244 Gly -> Ser 
(-) (+) 
(+) Exon 4 (-) 
Codon 107 Tyr -> stop 
(+) Exon 7 (-) 
Codon 234 Tyr -> stop 
(+) Exon 9 (-) 
Codon 326 Glu -> stop 
(-) (-) 
• Sample numbers arc different from those in Table II . 
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